133 related articles for article (PubMed ID: 30787673)
1. Re: 'Prostate cancer outcomes following whole-gland and focal high-intensity focused ultrasound'.
Besiroglu H
BJU Int; 2024 Jan; ():. PubMed ID: 38235931
[No Abstract] [Full Text] [Related]
2. Reply to: Letter to the editor regarding the article 'Prostate cancer outcomes following whole-gland and focal high-intensity focused ultrasound'.
Parry MG; Sujenthiran A; Nossiter J; Morris M; Berry B; Nathan A; Aggarwal A; Payne H; van der Meulen J; Clarke NW
BJU Int; 2024 Mar; ():. PubMed ID: 38515403
[No Abstract] [Full Text] [Related]
3. The FocAL therapy CONsensus (FALCON): enhancing partial gland ablation for localised prostate cancer.
Rodríguez-Sánchez L; Reiter R; Rodríguez A; Emberton M; de Reijke T; Compérat EM; Bossi A; Sanchez-Salas R
BJU Int; 2024 Apr; ():. PubMed ID: 38613454
[No Abstract] [Full Text] [Related]
4. Targeting the cancer lesion, not the whole prostate.
Bedi N; Reddy D; Ahmed HU
Transl Androl Urol; 2020 Jun; 9(3):1518-1525. PubMed ID: 32676439
[TBL] [Abstract][Full Text] [Related]
5. Erectile function after focal therapy for localized prostate cancer: a systematic review.
Fallara G; Capogrosso P; Maggio P; Taborelli A; Montorsi F; Dehò F; Salonia A
Int J Impot Res; 2021 May; 33(4):418-427. PubMed ID: 32999435
[TBL] [Abstract][Full Text] [Related]
6. A Prospective Pilot Study Investigating Performance of 18F-Fluciclovine PET Imaging for Detection of Prostate Cancer 2 Years Following Primary Partial Gland Cryoablation.
Nazemi A; Huang WC; Wysock J; Taneja SS; Friedman K; Gogaj R; Lepor H
Nucl Med Mol Imaging; 2022 Aug; 56(4):196-201. PubMed ID: 35846414
[TBL] [Abstract][Full Text] [Related]
7. Dual-Functional PLGA Nanoparticles Co-Loaded with Indocyanine Green and Resiquimod for Prostate Cancer Treatment.
Lin W; Li C; Xu N; Watanabe M; Xue R; Xu A; Araki M; Sun R; Liu C; Nasu Y; Huang P
Int J Nanomedicine; 2021; 16():2775-2787. PubMed ID: 33880023
[TBL] [Abstract][Full Text] [Related]
8. MRI guided procedure planning and 3D simulation for partial gland cryoablation of the prostate: a pilot study.
Wake N; Rosenkrantz AB; Sodickson DK; Chandarana H; Wysock JS
3D Print Med; 2020 Nov; 6(1):33. PubMed ID: 33141272
[TBL] [Abstract][Full Text] [Related]
9. Focal therapy, time to join the multi-disciplinary team discussion?
Reddy D; Bedi N; Dudderidge T
Transl Androl Urol; 2020 Jun; 9(3):1526-1534. PubMed ID: 32676440
[TBL] [Abstract][Full Text] [Related]
10. Early oncological control following partial gland cryo-ablation: a prospective experience specifying reflex MRI guided biopsy of the ablation zone.
Wysock JS; Becher E; Gogaj R; Velazquez N; Lepor H
Prostate Cancer Prostatic Dis; 2021 Mar; 24(1):114-119. PubMed ID: 32636487
[TBL] [Abstract][Full Text] [Related]
11. Prostate Cancer Screening and Management in Solid Organ Transplant Candidates and Recipients.
Becher E; Wang A; Lepor H
Rev Urol; 2019; 21(2-3):85-92. PubMed ID: 31768135
[TBL] [Abstract][Full Text] [Related]
12. New treatments for localized prostate cancer.
Marberger M; Carroll PR; Zelefsky MJ; Coleman JA; Hricak H; Scardino PT; Abenhaim LL
Urology; 2008 Dec; 72(6 Suppl):S36-43. PubMed ID: 19095127
[TBL] [Abstract][Full Text] [Related]
13. Current evidence for focal therapy and partial gland ablation for organ-confined prostate cancer: systematic review of literature published in the last 2 years.
Kayano PP; Klotz L
Curr Opin Urol; 2021 Jan; 31(1):49-57. PubMed ID: 33196540
[TBL] [Abstract][Full Text] [Related]
14. New and Established Technology in Focal Ablation of the Prostate: A Systematic Review.
Valerio M; Cerantola Y; Eggener SE; Lepor H; Polascik TJ; Villers A; Emberton M
Eur Urol; 2017 Jan; 71(1):17-34. PubMed ID: 27595377
[TBL] [Abstract][Full Text] [Related]
15. Oncological and Quality-of-life Outcomes Following Focal Irreversible Electroporation as Primary Treatment for Localised Prostate Cancer: A Biopsy-monitored Prospective Cohort.
Blazevski A; Scheltema MJ; Yuen B; Masand N; Nguyen TV; Delprado W; Shnier R; Haynes AM; Cusick T; Thompson J; Stricker P
Eur Urol Oncol; 2020 Jun; 3(3):283-290. PubMed ID: 31103721
[TBL] [Abstract][Full Text] [Related]
16. "Super-active surveillance": MRI ultrasound fusion biopsy and ablation for less invasive management of prostate cancer.
Bloom JB; Gold SA; Hale GR; Rayn KN; Sabarwal VK; Bakhutashvili I; Valera V; Turkbey B; Pinto PA; Wood BJ
Gland Surg; 2018 Apr; 7(2):166-187. PubMed ID: 29770311
[TBL] [Abstract][Full Text] [Related]
17. Focal Ablation of Prostate Cancer.
Lepor H; Gold S; Wysock J
Rev Urol; 2018; 20(4):145-157. PubMed ID: 30787673
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
